GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biolife Sciences Inc (OTCPK:BLFE) » Definitions » Research & Development

Biolife Sciences (Biolife Sciences) Research & Development : $0.00 Mil (TTM As of May. 2008)


View and export this data going back to 2005. Start your Free Trial

What is Biolife Sciences Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Biolife Sciences's Research & Development for the three months ended in May. 2008 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in May. 2008 was $0.00 Mil.

Biolife Sciences Research & Development Historical Data

The historical data trend for Biolife Sciences's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biolife Sciences Research & Development Chart

Biolife Sciences Annual Data
Trend Nov04 Nov05 Nov06 Nov07
Research & Development
- - - -

Biolife Sciences Quarterly Data
Nov04 Feb05 May05 Aug05 Nov05 Feb06 May06 Aug06 Nov06 Feb07 May07 Aug07 Nov07 Feb08 May08
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Biolife Sciences Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in May. 2008 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biolife Sciences  (OTCPK:BLFE) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Biolife Sciences Research & Development Related Terms

Thank you for viewing the detailed overview of Biolife Sciences's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Biolife Sciences (Biolife Sciences) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biolife Sciences Inc (OTCPK:BLFE) » Definitions » Research & Development
Comparable Companies
WAR:ERS TWER TSXV:VMY.H BOM:538674 FULO WAR:ECL ASX:REF TSXV:ECT XSAT:CHAL B WAR:AIT NSE:ACCORD WAR:TLG XCNQ:RVR DTGI OSTO:WIFOG WAR:U2K BOM:511116 ASX:ZIP JSE:TLM WAR:SFN
Traded in Other Exchanges
N/A
Address
2831 Street Rose Parkway, No. 200, Henderson, NV, USA, 89052
Website
https://www.biolifesciences.com
Biolife Sciences Inc is a commercialization accelerator, licensor and developer of innovative and disruptive technologies for the healthcare, beauty and food and beverage industry sectors. The company's technologies include antimicrobial copper air filters and copper-infused textiles. Its revenues are primarily generated from the sale of sanitation products.
Executives
Arthur Viola director, 10 percent owner, officer: CEO

Biolife Sciences (Biolife Sciences) Headlines

From GuruFocus

Rhino Novi Announces Name Change and New CEO

By Marketwired Marketwired • 09-15-2020